Cara Therapeutics is touting positive data from a trial in which its in-development treatment proved significantly less abuse-friendly than a commonly used opiate, results the company believes could make the drug a standout on the market.

…read more

Source: Cara’s pain drug clears an abuse hurdle as it trots toward Phase III


0 No comments